Back to
Nuveen Asset Management, LLC
VIVO
Showing 0 of 16 quarters
Position history for
Nuveen Asset Management, LLC's holdings in MERIDIAN BIOSCIENCE INC
As of its Q4 2022 13F, Nuveen Asset Management held 329,146 shares of VIVO (Meridian Bioscience), worth $10.9M. Nuveen Asset Management's 13F filings listed VIVO from Q2 2019 to Q4 2022, 15 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.